Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1874 studies found for:    "Liver Neoplasms"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Completed Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation
Condition: Liver Neoplasms
Intervention: Drug: perflutren lipid microspheres
2 Recruiting Study Evaluating the Efficacy and Safety With CAR-T for Liver Cancer
Condition: Liver Neoplasms
Intervention: Biological: EPCAM-targeted CAR-T cells
3 Active, not recruiting Hepatocellular Cancer (HCC) Screening in Zhongshan City
Condition: Liver Neoplasms
Intervention: Biological: Biomarker testing and Ultrasonography
4 Recruiting PET/CT-Assessment of Liver Tumor Ablation
Conditions: Liver Tumor;   Liver Neoplasms
Interventions: Radiation: N-13 ammonia or F-18 fluorodeoxyglucose;   Diagnostic Test: PET scan
5 Completed Single-probe Microwave Ablation (MWA) of Metastatic Liver Cancer
Condition: Liver Neoplasms
Interventions: Device: Microwave ablation;   Device: Radiofrequency ablation
6 Recruiting Percutaneous Microwave Ablation Under Ultrasound Guidance for Liver Cancer: a Multicenter Analysis
Condition: Liver Neoplasms
Intervention: Procedure: microwave ablation device
7 Withdrawn Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer
Condition: Liver Neoplasms
Intervention: Drug: Temsirolimus 25mg and Pegylated liposomal doxorubicin 25mg/m2
8 Withdrawn SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer
Condition: Liver Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: lonafarnib;   Procedure: conventional surgery
9 Terminated
Has Results
A Phase II Trial of OSI-906 and Sorafenib in Advanced Hepatocellular Cancer
Condition: Liver Cancer
Intervention: Drug: Sorafenib and OSI-906
10 Completed
Has Results
Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial
Condition: Liver Cancer
Intervention: Drug: lenalidomide
11 Not yet recruiting Feasibility of Electromagnetic Acoustic Imaging of Liver Tumours
Condition: Liver Tumours
Intervention: Device: Electromagnetic Acoustic Imaging
12 Active, not recruiting Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer
Conditions: Hepatocellular Cancer;   Liver Cancer
Intervention: Drug: OMP-54F28 with Sorafenib
13 Active, not recruiting Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer
Condition: Liver Cancer
Intervention: Drug: Lipiodol
14 Terminated Taxoprexin® Treatment for Advanced Primary Cancers of the Liver
Condition: Cancer of the Liver
Intervention: Drug: Taxoprexin
15 Completed Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer
Condition: Liver Cancer
Interventions: Biological: DC-CIK cells;   Biological: γδ T cells;   Biological: γδ T/DC-CIK cells
16 Completed HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Liver Cancer
Condition: Liver Cancer
Intervention: Procedure: interventional therapy
17 Completed Liver Cancer HepaSphere Combined With Cryosurgery
Condition: Liver Cancer
Intervention: Procedure: HepaSphere combined with cryosurgery
18 Withdrawn Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer
Condition: Liver Cancer
Interventions: Genetic: comparative genomic hybridization;   Genetic: molecular genetic technique;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: proteomic profiling;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: mass spectrometry;   Other: medical chart review
19 Completed A Retrospective Review of Malignant Liver Tumors
Condition: Liver Cancer
20 Completed Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer
Condition: Liver Cancer
Interventions: Drug: alvocidib;   Drug: irinotecan hydrochloride

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.